www.cancerresearch.org In 2004 Dr. Arthur Frankel and his team of researchers were recruited from Wake Forest University School of Medicine to join Scott & White and the A&M College of Medicine. To accommodate Dr. Frankel's team, Scott & White constructed the Cancer Research Institute on its West Campus in Temple.
For Central Texas patients, the Institute means ready access to second opinions and innovative treatments for some of the world's deadliest diseases. For the academic world, the Institute represents a true partnership between research and patient care.
By working closely with pharmaceutical companies from the US and abroad, entrepreneurs and the Food and Drug Administration, the CRI team hopes to bring new therapeutics from molecular design to patient care in less than half the traditional time required.
Drugs currently being studied include potential treatments for melanoma, leukemia, brain tumors, lung cancer and prostate cancer.
